FP.17 Long-term follow-up of cipaglucosidase alfa/miglustat in ambulatory patients with Pompe disease: An open-label phase I/II study (ATB200-02)
Saved in:
Published in | Neuromuscular disorders : NMD Vol. 32; p. S73 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.10.2022
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0960-8966 |
---|---|
DOI: | 10.1016/j.nmd.2022.07.130 |